Hypoxia not only contributes to tumor formation but is also involved in developing chemoresistance in GBM37, in part through activating hypoxia-inducible factor-1 alpha (HIF-1α) expression and its downstream signaling pathways. This evidence concerns the gene HIF1A and neoplasm.